Doctor from Vanderbilt who was on after the announcement of plasma, on Fox, was not at all positive about the plasma EUA. One thing he stated is that this will have a negative impact on convincing new participants to enter a trial for another drug, such as ours. Good point since if your health is deteriorating most people will choose to go with what is approved. Makes the job of meeting the participants required in all studies more difficult. Remdesivir also had the same effect.